MeSH tree: D03.383.621
New research explains how low levels of the electrolyte sodium in the blood can disrupt the timing of the heartbeat in patients taking widely used rhythm-control medications such as flecainide, which is commonly prescribed ...
Jul 15, 2025
0
31
Even four years after the start of the COVID-19 pandemic, California residents aren't living as long as they used to.
Jul 10, 2025
0
14
Speedballing—the practice of combining a stimulant like cocaine or methamphetamine with an opioid such as heroin or fentanyl—has evolved from a niche subculture to a widespread public health crisis. The practice stems from ...
Jul 3, 2025
0
46
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity disorder (ADHD) medications, including certain formulations of amphetamine and methylphenidate, to warn ...
Jul 3, 2025
0
17
The US Food and Drug Administration (FDA) has issued an urgent warning about tianeptine—a substance marketed as a dietary supplement but known on the street as "gas station heroin."
Jul 2, 2025
0
23
The illicit secrets are in the sewage.
Jul 1, 2025
0
19
Homelessness and opioid use disorder are two widespread public health problems in the United States. Providing housing and supportive services, without requiring drug treatment, is a surprisingly cost-effective approach to ...
Jun 27, 2025
0
37
Opioids like fentanyl, morphine and oxycodone are the drugs most linked to overdoses in the U.S. Typical screening methods for drug usage involve collection of blood, saliva or urine samples. Now, in Analytical Chemistry, ...
Jun 24, 2025
0
29
The U.S. Food and Drug Administration has approved Monjuvi (tafasitamab-cxix) for the treatment of adult patients with relapsed or refractory follicular lymphoma.
Jun 23, 2025
0
14
Many parents are surprised to learn that attention-deficit/hyperactivity disorder (ADHD) and struggles with bladder control, or toileting issues, often go hand-in-hand.
Jun 16, 2025
0
42
